Figure 2
GZ17-6.02 inhibits the growth of MF cells. (A) Representative dose–response curve for GZ17-6.02 against HH cells. (B) Representative dose–response curve for GZ17-6.02 against MyLa cells. (C) Percentage of HH and MyLa cells in early and late apoptosis following incubation with increasing concentrations of GZ17-6.02. (D) Western blot of cleaved PARP in HH and MyLa cells following incubation with increasing concentrations of GZ17-6.02. (E) Normalized expression of western blot experiments showing increased cleaved PARP with increasing concentrations of GZ17-6.02 in HH and MyLa cells. The blots for HH and MyLa show in this figure were taken from separate gels. *p < .05; **p < .01; ***p < .001; apo, apoptosis; cPARP, cleaved PARP.
